XERS
Xeris Biopharma·NASDAQ
--
--(--)
--
--(--)
4.65 / 10
Netural
Technical score is 4.65, neutral overall. A bullish MACD Golden Cross (score 8.27) and Marubozu White (6.06) support upside, while Long Lower and Upper Shadows (scores 1 and 3.27) signal bearish pressure. Market direction remains unclear.
Analysis Checks(2/4)
Long Lower Shadow
Score1/10
Win Rate37.50%
Hist. Signals16
Avg Return-2.56%
Score1/10
Win Rate37.50%
Hist. Signals16
Avg Return-2.56%
MACD Golden Cross
Score8.27/10
Win Rate75.00%
Hist. Signals8
Avg Return2.41%
Score8.27/10
Win Rate75.00%
Hist. Signals8
Avg Return2.41%
Long Upper Shadow
Score3.27/10
Win Rate47.83%
Hist. Signals23
Avg Return0.72%
Score3.27/10
Win Rate47.83%
Hist. Signals23
Avg Return0.72%
Marubozu White
Score6.06/10
Win Rate60.00%
Hist. Signals5
Avg Return0.79%
Score6.06/10
Win Rate60.00%
Hist. Signals5
Avg Return0.79%
Long Lower Shadow
Score1/10
Win Rate37.50%
Hist. Signals16
Avg Return-2.56%
Score1/10
Win Rate37.50%
Hist. Signals16
Avg Return-2.56%
Long Upper Shadow
Score3.27/10
Win Rate47.83%
Hist. Signals23
Avg Return0.72%
Score3.27/10
Win Rate47.83%
Hist. Signals23
Avg Return0.72%
MACD Golden Cross
Score8.27/10
Win Rate75.00%
Hist. Signals8
Avg Return2.41%
Score8.27/10
Win Rate75.00%
Hist. Signals8
Avg Return2.41%
Marubozu White
Score6.06/10
Win Rate60.00%
Hist. Signals5
Avg Return0.79%
Score6.06/10
Win Rate60.00%
Hist. Signals5
Avg Return0.79%
Technical Analysis of XERS?
- XERS presents a Netural setup with a Technical Score of 4.65/10. Key technical indicators highlight an RSI of 54.09 and a MACD of 0.23, with the trend anchored by the 50-Day SMA at 6.37. Traders should monitor key support at 5.90 and resistance at 6.14.
